Thermo Fisher will sell Synthego's synthetic guide RNA products under the Invitrogen TrueGuide brand.
The company launched the RxMatch Antidepressant Panel as the first step to grow beyond precision oncology and offer genomic assays for a wider range of diseases.
Under the partnership, DNAnexus customers will have direct access to the Dragen Genome Pipeline for "ultra-rapid" genome analysis.
The agreement, which covers Interpace's ThyGenX and ThyraMIR diagnostic tests for the diagnosis of thyroid cancer in patients with indeterminate thyroid nodules.
Zogen will market and promote OncoDNA's genomic testing and data interpretation services to oncologists in Mexico.
Supercomputing powerhouse Cray has entered into a partnership with cloud host Markley Group, a player in Boston's biotech and genomics communities.
Under the terms of the deal, HDB will have access to Luxcel's assays and technologies for mitochondrial function, metabolism, and toxicity.
LifeCodexx's PrenaTest will be available to women in Malaysia, Singapore, Thailand, Brunei, Vietnam, the United Arab Emirates, and elsewhere in the Middle East.
BKare will provide marketing and certain other services to Vantari, which offers genetic testing, as well as molecular laboratory and toxicology services.
Agilent and CRO PureHoney will develop new applications for the RapidFire 365 system, including workflows for pharmaceutical research, forensics, and metabolomics.
New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.
Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.
La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.
In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.